Učitavanje...
CAR models: next-generation CAR modifications for enhanced T-cell function
T cells genetically targeted with a chimeric antigen receptor (CAR) to B-cell malignancies have demonstrated tremendous clinical outcomes. With the proof in principle for CAR T cells as a therapy for B-cell malignancies being established, current and future research is being focused on adapting CAR...
Spremljeno u:
| Izdano u: | Mol Ther Oncolytics |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4871190/ https://ncbi.nlm.nih.gov/pubmed/27231717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mto.2016.14 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|